Document

Emerging gene editing approaches pave the way for safer, more successful transplants.

Detecting tumor antigens is key to developing effective cancer diagnostics, immunotherapies, and vaccines.

Cell-free gene synthesis technology offers a quick, reliable route to creating vital mRNA vaccines and therapeutics. 

Spatial transcriptomics technologies unveil a goldmine of biological information.

Biobanking gives scientists access to thousands of biological samples, moving precision medicine one step closer to reality.

Many of the same therapies used to activate the immune system against cancer may also combat infectious diseases.

Antimicrobial resistance poses a significant threat to healthcare. Ultra-microscopic viruses called bacteriophages might hold a solution.

Highly potent antibody candidates isolated via advanced flow cytometry is growing the list of approved therapeutic antibodies.

How do scientists delve into the spatial dimensions of cancer biology to make new discoveries?  

The blood-brain barrier seems impenetrable, but new therapeutic antibodies may creep past its defenses. 

Some infectious diseases require unique modifications to the traditional vaccine development approach.  

By directly and precisely destroying troublesome proteins, PROTAC molecules emerge as effective tools for enhancing cancer treatment.

Different precision medicine approaches modulate distinct pathways to treat cancer, but how do scientists know which approach is best?

A collaborative team overcomes the long-standing challenge of blurred imaging, illuminating once hidden details within the depths of thick samples.

Epigenetic events shape cancer initiation and progression. By targeting mechanisms involved in epigenetic regulation, epigenetic therapeutics serve as effective weapons against cancer.

Capillary electrophoresis detects issues such as point mutations in mRNA therapeutics and contaminants in cell and gene therapies.

Breakthroughs in flow cytometry enable scientists to profile complex and rare immune cell populations. 

New technologies keep CRISPR/Cas9 in check and minimize off-target risks.

Advanced proteomics tools aid in biomarker discovery and pave the way for precision  medicine.

A coordinated effort between the stroma, the immune system, and the skin microbiome restores damaged skin.